342 related articles for article (PubMed ID: 18497949)
21. Induction of anergy in human T helper 0 cells by stimulation with altered T cell antigen receptor ligands.
Tsitoura DC; Holter W; Cerwenka A; Gelder CM; Lamb JR
J Immunol; 1996 Apr; 156(8):2801-8. PubMed ID: 8609399
[TBL] [Abstract][Full Text] [Related]
22. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
23. HLA class I-restricted recognition of an HIV-derived epitope peptide by a human T cell receptor alpha chain having a Vdelta1 variable segment.
Ueno T; Tomiyama H; Fujiwara M; Oka S; Takiguchi M
Eur J Immunol; 2003 Oct; 33(10):2910-6. PubMed ID: 14515275
[TBL] [Abstract][Full Text] [Related]
24. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
Castelli FA; Leleu M; Pouvelle-Moratille S; Farci S; Zarour HM; Andrieu M; Auriault C; Ménez A; Georges B; Maillere B
Eur J Immunol; 2007 Jun; 37(6):1513-23. PubMed ID: 17492804
[TBL] [Abstract][Full Text] [Related]
25. MHC class II binding of peptides derived from HLA-DR 1.
Harris PE; Liu Z; Suciu-Foca N
J Immunol; 1992 Apr; 148(7):2169-74. PubMed ID: 1545124
[TBL] [Abstract][Full Text] [Related]
26. Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer.
Mittendorf EA; Gurney JM; Storrer CE; Shriver CD; Ponniah S; Peoples GE
Surgery; 2006 Mar; 139(3):407-18. PubMed ID: 16546506
[TBL] [Abstract][Full Text] [Related]
27. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
Berthelot L; Laplaud DA; Pettré S; Ballet C; Michel L; Hillion S; Braudeau C; Connan F; Lefrère F; Wiertlewski S; Guillet JG; Brouard S; Choppin J; Soulillou JP
Eur J Immunol; 2008 Jul; 38(7):1889-99. PubMed ID: 18506883
[TBL] [Abstract][Full Text] [Related]
28. A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis.
Penzotti JE; Doherty D; Lybrand TP; Nepom GT
J Autoimmun; 1996 Apr; 9(2):287-93. PubMed ID: 8738976
[TBL] [Abstract][Full Text] [Related]
29. Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides.
de Haan EC; Wagenaar-Hilbers JP; Liskamp RM; Moret EE; Wauben MH
Mol Immunol; 2005 Feb; 42(3):355-64. PubMed ID: 15589324
[TBL] [Abstract][Full Text] [Related]
30. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation.
Chen YZ; Matsushita S; Nishimura Y
J Immunol; 1996 Nov; 157(9):3783-90. PubMed ID: 8892606
[TBL] [Abstract][Full Text] [Related]
31. Taxol increases the amount and T cell activating ability of self-immune stimulatory multimolecular complexes found in ovarian cancer cells.
Tsuda N; Chang DZ; Mine T; Efferson C; García-Sastre A; Wang X; Ferrone S; Ioannides CG
Cancer Res; 2007 Sep; 67(17):8378-87. PubMed ID: 17804754
[TBL] [Abstract][Full Text] [Related]
32. Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules.
Hess AD; Thoburn CJ; Chen W; Bright AE
Transplantation; 2003 Apr; 75(8):1361-7. PubMed ID: 12717231
[TBL] [Abstract][Full Text] [Related]
33. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
[TBL] [Abstract][Full Text] [Related]
34. CD4+ T-cell activation for immunotherapy of malignancies using Ii-Key/MHC class II epitope hybrid vaccines.
Xu M; Kallinteris NL; von Hofe E
Vaccine; 2012 Apr; 30(18):2805-10. PubMed ID: 22386748
[TBL] [Abstract][Full Text] [Related]
35. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
[TBL] [Abstract][Full Text] [Related]
36. Functionally divergent T lymphocyte responses induced by modification of a self-peptide from a tumor-associated antigen.
Hess AD; Thoburn CJ; Miura Y; Bright EC
Clin Immunol; 2005 Mar; 114(3):307-19. PubMed ID: 15721842
[TBL] [Abstract][Full Text] [Related]
37. A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells.
Hedlund G; Dohlsten M; Herrmann T; Buell G; Lando PA; Segrén S; Schrimsher J; MacDonald HR; Sjögren HO; Kalland T
J Immunol; 1991 Dec; 147(12):4082-5. PubMed ID: 1753087
[TBL] [Abstract][Full Text] [Related]
38. Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.
Maccalli C; Di Cristanziano V; Fodale V; Corsi D; D'Agostino G; Petrangeli V; Laurenti L; Guida S; Mazzocchi A; Arienti F; Perrone MP; Castelli C; Rivoltini L; Zagonel V; Tartaglia M; Parmiani G; Belardelli F
Clin Cancer Res; 2008 Nov; 14(22):7292-303. PubMed ID: 18974390
[TBL] [Abstract][Full Text] [Related]
39. Ii-Key/HPV16 E7 hybrid peptide immunotherapy for HPV16+ cancers.
Xu M; Lu X; Sposato M; Zinckgraf JW; Wu S; von Hofe E
Vaccine; 2009 Jul; 27(34):4641-7. PubMed ID: 19520206
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8+ T cells fail to control tumor growth despite interferon-gamma production in patients with cervical cancer.
Zehbe I; Kaufmann AM; Schmidt M; Hohn H; Maeurer MJ
J Immunother; 2007; 30(5):523-32. PubMed ID: 17589293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]